1-3 of 3
Francesco Grossi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer

Alessio Cortellini, Antonio D'Alessio, Siobhan Cleary, Sebastiano Buti, Melissa Bersanelli, Paola Bordi, Giuseppe Tonini, Bruno Vincenzi, Marco Tucci, Alessandro Russo, Francesco Pantano, Marco Russano, Luigia Stefania Stucci, Maria Chiara Sergi, Martina Falconi, Maria Antonietta Zarzana, Daniele Santini, Francesco Spagnolo, Enrica T. Tanda, Francesca Rastelli, Francesca Chiara Giorgi, Federica Pergolesi, Raffaele Giusti, Marco Filetti, Francesca Lo Bianco, Paolo Marchetti, Andrea Botticelli, Alain Gelibter, Marco Siringo, Marco Ferrari, Riccardo Marconcini, Maria Giuseppa Vitale, Linda Nicolardi, Rita Chiari, Michele Ghidini, Olga Nigro, Francesco Grossi, Michele De Tursi, Pietro Di Marino, Paola Queirolo, Sergio Bracarda, Serena Macrini, Alessandro Inno, Federica Zoratto, Enzo Veltri, Chiara Spoto, Maria Grazia Vitale, Katia Cannita, Alessandra Gennari, Daniel L. Morganstein, Domenico Mallardo, Lorenzo Nibid, Giovanna Sabarese, Leonardo Brunetti, Giuseppe Perrone, Paolo A. Ascierto, Corrado Ficorella, David J. Pinato
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (14): 2714–2724.
https://doi.org/10.1158/1078-0432.CCR-22-3116
Published: 14 July 2023
View article titled, Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer
Open the PDF for Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer in another window
Includes: Supplementary data
Journal Articles

Crizotinib in MET-Deregulated or ROS1-Rearranged Pretreated Non–Small Cell Lung Cancer (METROS): A Phase II, Prospective, Multicenter, Two-Arms Trial

Lorenza Landi, Rita Chiari, Marcello Tiseo, Federica D'Incà, Claudio Dazzi, Antonio Chella, Angelo Delmonte, Laura Bonanno, Diana Giannarelli, Diego Luigi Cortinovis, Filippo de Marinis, Gloria Borra, Alessandro Morabito, Cesare Gridelli, Domenico Galetta, Fausto Barbieri, Francesco Grossi, Enrica Capelletto, Gabriele Minuti, Francesca Mazzoni, Claudio Verusio, Emilio Bria, Greta Alì, Rossella Bruno, Agnese Proietti, Gabriella Fontanini, Lucio Crinò, Federico Cappuzzo
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2019) 25 (24): 7312–7319.
https://doi.org/10.1158/1078-0432.CCR-19-0994
Published: 13 December 2019
View article titled, Crizotinib in <em>MET</em>-Deregulated or <em>ROS1</em>-Rearranged Pretreated Non–Small Cell Lung Cancer (METROS): A Phase II, Prospective, Multicenter, Two-Arms Trial
Open the PDF for Crizotinib in <em>MET</em>-Deregulated or <em>ROS1</em>-Rearranged Pretreated Non–Small Cell Lung Cancer (METROS): A Phase II, Prospective, Multicenter, Two-Arms Trial in another window
Includes: Supplementary data
Journal Articles

Buccal Mucosa Cells as In vivo Model to Evaluate Gefitinib Activity in Patients with Advanced Non–Small Cell Lung Cancer

Maura Loprevite, Marcello Tiseo, Maurizio Chiaramondia, Marzia Capelletti, Cecilia Bozzetti, Beatrice Bortesi, Nadia Naldi, Rita Nizzoli, Patrizia Dadati, Annalisa Kunkl, Daniela Zennaro, Costanza Lagrasta, Nicoletta Campanini, Elena Spiritelli, Roberta Camisa, Francesco Grossi, Guido Rindi, Vittorio Franciosi, Andrea Ardizzoni
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (21): 6518–6526.
https://doi.org/10.1158/1078-0432.CCR-07-0805
Published: 01 November 2007
View article titled, Buccal Mucosa Cells as <em>In vivo</em> Model to Evaluate Gefitinib Activity in Patients with Advanced Non–Small Cell Lung Cancer
Open the PDF for Buccal Mucosa Cells as <em>In vivo</em> Model to Evaluate Gefitinib Activity in Patients with Advanced Non–Small Cell Lung Cancer in another window